MentionFox
Home › Who owns › Pacira BioSciences Inc
Owners, funding and legal record

Who owns Pacira BioSciences Inc? Owners, funding and legal record

Before you sign with, sell to or invest in Pacira BioSciences Inc

MentionFox check on Pacira BioSciences Inc: no red flags found in 12 sources (checked 6 November 2026). mentionfox.com/c/who-owns/pacira-biosciences

Check Pacira BioSciences Inc before you sign, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Pacira BioSciences Inc?

Pacira BioSciences Inc is a publicly traded company (Nasdaq: PCRX). The most recent 5%+ ownership report names State Street holding 5.2% (Schedule 13G, filed 2026-08-07).

As of November 6, 2026, Pacira BioSciences Inc is a publicly traded company (Nasdaq: PCRX); its largest reported holder is Vanguard, with 6.38% on Schedule 13G of May 1, 2026, then State Street (5.2%). The largest insider holding is Frank D. Lee, the chief executive and a director, with 660,830.84 shares (1.6% of shares outstanding), per Form 4 of February 13, 2026 (Schedule 13G, May 1, 2026).

Renaissance Technologies LLC also filed stake reports on 46 other companies ↓

Is this your company?

About to sign with, pay or invest in Pacira BioSciences Inc? See the free Snapshot first.

Watch Pacira BioSciences Inc

Free to see. No signup.

Is Pacira BioSciences Inc a real, registered company?

Before you sign or pay

Who are Pacira BioSciences Inc's owners and officers?

Pacira BioSciences Inc: incorporated in Delaware; business address in Brisbane, California; industry Pharmaceutical Preparations (Schedule 13G/A, 2026-10-30).

ReportHolderShare
Schedule 13G/A, 2026-10-30Vanguard Capital Management4.82%
Schedule 13D/A, 2026-10-13Doma Perpetual Capital Management LLC0%
Schedule 13G, 2026-08-07State Street Corporation5.2%
Schedule 13G, 2026-05-01Vanguard Portfolio Management6.38%
Schedule 13G, 2026-05-01Vanguard Capital Management5.15%
Schedule 13G, 2026-04-09Dimensional Fund Advisors LP5.1%
Schedule 13G/A, 2026-03-27The Vanguard Group0%
Schedule 13D/A, 2026-03-12Doma Perpetual Capital Management LLC7.3%
Schedule 13D/A, 2026-01-02Doma Perpetual Capital Management LLC6.83%
Schedule 13G/A, 2025-11-13Renaissance Technologies LLC4.98%
Schedule 13D/A, 2025-11-10Doma Perpetual Capital Management LLC6.83%
Schedule 13G, 2025-08-13Renaissance Technologies LLC5.34%

Questions about who owns Pacira BioSciences Inc

Who owns Pacira BioSciences Inc?

On this page, 3 holders' latest ownership filings report 5% or more of Pacira BioSciences Inc: Vanguard Portfolio Management (6.38%, Schedule 13G, filed 2026-05-01), State Street Corporation (5.2%, Schedule 13G, filed 2026-08-07) and Dimensional Fund Advisors LP (5.1%, Schedule 13G, filed 2026-04-09).

Who are the largest shareholders of Pacira BioSciences Inc?

By the share each holder's latest filing reports, the largest holders of Pacira BioSciences Inc on this page are Vanguard Portfolio Management (6.38%), State Street Corporation (5.2%) and Dimensional Fund Advisors LP (5.1%).

When did Vanguard Portfolio Management buy into Pacira BioSciences Inc?

The filings give report dates, not purchase dates. The earliest filing from Vanguard Portfolio Management on this page is the Schedule 13G, filed 2026-05-01, reporting 6.38%.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 12 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Want the whole picture on Pacira BioSciences Inc?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Pacira BioSciences Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Pacira BioSciences Inc covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    18 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

Which insiders own Pacira BioSciences Inc shares?

Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.

Shares outstanding: 40,094,660 as of 2026-11-04, from the company's latest SEC cover page.

How much has Pacira BioSciences Inc raised?

No fundraising or offering filing from Pacira BioSciences Inc is on file with us.

Keep reading

More on Pacira BioSciences Inc and the records around it.

Pacira BioSciences Inc elsewhere on the record

Companies that share a holder

Related pages

Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.

Not for employment, credit, insurance or tenancy decisions.

Cite this page

Permanent URL: https://mentionfox.com/who-owns/pacira-biosciences
Last updated 2026-11-06
Primary record: Schedule 13G, 2026-08-07
Who owns Pacira BioSciences? Nasdaq: PCRX; Vanguard 6.38%. MentionFox, 2026-11-06. https://mentionfox.com/who-owns/pacira-biosciences